Results 1 to 10 of about 286,184 (123)

Experience of using a complex bioregulatory drug in young children

Медицинский совет, 2021
Introduction. The paper presents modern insights into the pathogenesis and role of inflammatory reactions in the developmentof the respiratory pathology.
Khakim M. Vakhitov, Alina G. Makhmutiva, Lilia F. Vakhitova   +2 more
doaj   +4 more sources

APPLICATION OF COMPLEX BIOREGULATORY DRUGS IN MODERN DENTAL PRACTICE (REVIEW OF LITERATURE)

Український стоматологічний альманах, 2020
In the research for the highly efficient, wide spectrum, safe drugs, dental practitioners in recent years have been increasingly paying attention to complex bioregulatory drugs (CBDs). They affect the body in small doses, initiate, activate and regulate
S.P. Yarova, E.O. Yurina, Y.Y. Yarov, S.E. Yurin   +3 more
doaj   +4 more sources

Adjuvant therapy of osteoarthritis with bioregulatory drugs

Современная ревматология
Osteoarthritis (OA) is a chronic progressive joint disease that ranks first in the frequency of all musculoskeletal diseases. OA is a serious general medical and social problem associated with a steady increase in prevalence.
E. G. Zotkin, S. Yu. Shkireeva
doaj   +4 more sources

Bioregulatory drugs in osteoarthritis management

Медицинский совет, 2019
Osteoarthritis (OA) is a degenerative joint disease. Modern theories consider various structural (cartilage destruction) and biophysical disorders (matrix loss of glycosaminoglycans) as the basis of acute and chronic pain syndrome.
O. A. Shavlovskaya
doaj   +2 more sources

Respiratory viral infections: approaches to therapy from the perspective of clinical and pathogenetic aspects of the disease

Медицинский совет, 2022
Introduction. Acute respiratory viral infections in children remain an urgent problem, not only because of the high incidence, but also a significant contribution to the mortality structure of young children.
G. V. Santalova, S. V. Plakhotnikova
doaj   +1 more source

Possibilities of correction of post viral other dysfunction in the application of COVID-19

Медицинский совет, 2021
Introduction. One of the characteristic manifestations of COVID-19 is a disorder of smell, which, according to the literature, occurs in 61.2% - 85.6% of patients with COVID-19.
T. Yu. Vladimirova, L. A. Baryshevskaya, A. V. Kurenkov   +2 more
doaj   +1 more source

Treatment of inflammatory diseases of the nose and paranasal sinuses from the standpoint of bioregulatory systemic medicine

Медицинский совет, 2022
One of the most frequent otorhinolaryngological pathologies is inflammatory diseases of the nose and paranasal sinuses. In Russia, according to the Ministry of Health and Social Development, 15% of adults and 5% of children suffer from chronic ...
V. V. Dvoryanchikov, G. S. Maltseva, S. S. Pavlova, V. V. Turieva   +3 more
doaj   +1 more source

Bioregulatory therapy in the treatment and prevention of upper respiratory tract diseases in children

Медицинский совет, 2020
Influenza and other acute respiratory viral infections (ARVI) are among the most widespread infectious diseases, accounting for up to 90—95% annually in the structure of the registered infectious morbidity. According to the World Health Organization (WHO)
T. I. Garashchenko, E. P. Selkova, O. V. Karneeva, M. V. Garashchenko, A. S. Oganesyan   +4 more
doaj   +1 more source

Viburcol — Bioregulatory Approach in Childhood Diseases

Zdorovʹe Rebenka, 2015
One of the most urgent problems of modern pediatrics and neonatology is a need for drugs, which, along with proven efficacy, also will have maximal safety for a growing child’s body.
S.V. Popovich
doaj   +1 more source

Bioregulation therapy in treatment of fever and hyperthermia

Лечащий Врач, 2021
Therapy of fever and hyperthermia is considered. In addition to the Federal Clinical Guidelines for the provision of emergency medical care for acute fever in children, the use of the bioregulatory drug is presented.
E. V. Konopleva
doaj